Koei Chemical Company, Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Koei Chemical Company, Limited with three other
companies in this sector in Japan:
Biofermin Pharmaceutical Company Limited
sales of 9.67 billion Japanese Yen [US$86.80 million]
of which 62%
was New BioferminS),
Wakamoto Pharmaceutical Co., Ltd.
(11.18 billion Japanese Yen [US$100.43 million]
of which 51%
was Medical Pharmaceutical Products), and
(30.96 billion Japanese Yen [US$278.04 million]
of which 82%
was Pharmaceutical Products).
Koei Chemical Company, Limited reported sales of ¥18.28 billion (US$164.15 million)
March of 2016.
decrease of 2.1%
versus 2015, when the company's sales were ¥18.66 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Koei Chemical Company, Limited had sales
of ¥19.95 billion.